Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 1261: A preneoplastic switch to glycolytic metabolism driven by a PI3K-induced transcriptional program

View through CrossRef
Abstract Most cancer cells exhibit a peculiar metabolic behavior, producing energy by aerobic glycolysis instead of oxidative phosphorylation (Warburg effect). Several oncogenes directly drive this switch modulating the levels and activity of, among others, Hexokinase II, Lactate Dehydrogenase A, Pyruvate Kinase M2, and Pyruvate Dehydrogenase Kinase 1. We have generated a Pten-/- mouse model in which the PI3K pathway is selectively activated in the thyroid epithelial cells, leading to hyperplasia which later progresses to follicular carcinoma. Using proteomics to identify proteins differentially expressed in early hyperplastic lesions, we have found that the levels of many tricarboxylic acid cycle proteins are down-regulated in mutant thyroids. Down-regulation of these proteins is due to reduced mRNA expression, and results in reduced oxidative phosphorylation and enhanced glycolysis (over 3-fold increase in lactate production in mutants vs. wt). Furthermore, although mutant thyroids cells have a normal number of mitochondria, the expression of most mitochondrially-encoded genes is heavily down-regulated. Strikingly, none of the genes and proteins classically associated with the Warburg effect is found deregulated in the mutant thyroid cells. Analysis of the expression of transcription factors and co-activators involved in cellular metabolism revealed that the decrease in TCA cycle and OXPHOS genes is due to a reduction in ERRα, ERRγ, PPARα and PPARγ levels. Conversely, none of the co-activators analyzed (PRC1, PGC-1α, and PGC-1β) exhibited changes in mRNA expression. Pharmacological and genetic PI3K inhibition in mouse tumor-derived thyroid cancer cell lines increased the expression levels of both TCA cycle OXPHOS genes. Moreover, it also increased mtDNA amount, suggesting that the transition from hyperplasia to cancer involves additional alterations of the metabolic machinery. Likewise, PI3K inhibition induced a marked decrease in lactate secretion. Finally, these thyroid cancer cell lines exhibited high sensitivity to glycolysis inhibitors such as 3-bromopyruvate. Based on these compelling data, we propose a novel mechanism leading to the Warburg effect in preneoplastic lesions: PI3K activation initiates a coordinated rearrangement of the expression of metabolic genes, which favors aerobic glycolysis at the expense of TCA/OXPHOS. The elucidation of this process will lead to innovative targeted approaches to selectively disrupt tumor progression, while preserving normal metabolism in non mutated cells. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1261. doi:10.1158/1538-7445.AM2011-1261
American Association for Cancer Research (AACR)
Title: Abstract 1261: A preneoplastic switch to glycolytic metabolism driven by a PI3K-induced transcriptional program
Description:
Abstract Most cancer cells exhibit a peculiar metabolic behavior, producing energy by aerobic glycolysis instead of oxidative phosphorylation (Warburg effect).
Several oncogenes directly drive this switch modulating the levels and activity of, among others, Hexokinase II, Lactate Dehydrogenase A, Pyruvate Kinase M2, and Pyruvate Dehydrogenase Kinase 1.
We have generated a Pten-/- mouse model in which the PI3K pathway is selectively activated in the thyroid epithelial cells, leading to hyperplasia which later progresses to follicular carcinoma.
Using proteomics to identify proteins differentially expressed in early hyperplastic lesions, we have found that the levels of many tricarboxylic acid cycle proteins are down-regulated in mutant thyroids.
Down-regulation of these proteins is due to reduced mRNA expression, and results in reduced oxidative phosphorylation and enhanced glycolysis (over 3-fold increase in lactate production in mutants vs.
wt).
Furthermore, although mutant thyroids cells have a normal number of mitochondria, the expression of most mitochondrially-encoded genes is heavily down-regulated.
Strikingly, none of the genes and proteins classically associated with the Warburg effect is found deregulated in the mutant thyroid cells.
Analysis of the expression of transcription factors and co-activators involved in cellular metabolism revealed that the decrease in TCA cycle and OXPHOS genes is due to a reduction in ERRα, ERRγ, PPARα and PPARγ levels.
Conversely, none of the co-activators analyzed (PRC1, PGC-1α, and PGC-1β) exhibited changes in mRNA expression.
Pharmacological and genetic PI3K inhibition in mouse tumor-derived thyroid cancer cell lines increased the expression levels of both TCA cycle OXPHOS genes.
Moreover, it also increased mtDNA amount, suggesting that the transition from hyperplasia to cancer involves additional alterations of the metabolic machinery.
Likewise, PI3K inhibition induced a marked decrease in lactate secretion.
Finally, these thyroid cancer cell lines exhibited high sensitivity to glycolysis inhibitors such as 3-bromopyruvate.
Based on these compelling data, we propose a novel mechanism leading to the Warburg effect in preneoplastic lesions: PI3K activation initiates a coordinated rearrangement of the expression of metabolic genes, which favors aerobic glycolysis at the expense of TCA/OXPHOS.
The elucidation of this process will lead to innovative targeted approaches to selectively disrupt tumor progression, while preserving normal metabolism in non mutated cells.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL.
Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1261.
doi:10.
1158/1538-7445.
AM2011-1261.

Related Results

L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity
L-Asparaginase More Effectively Targets Leukemic Cells with Low Glycolytic Activity
Abstract Since O. Warburg first proposed aerobic glycolysis to be the main bioenergetic pathway activated in cancer cells, there has been near silence on the differe...
Abstract 301: Galectin-1 modulates PI3 kinase activity
Abstract 301: Galectin-1 modulates PI3 kinase activity
Abstract The purpose of these experiments was to study the role that Galectin-1 (GAL1) has in Phosphoinositide 3-kinase (PI3K) signaling. GAL1 protein levels have be...
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract Objective: To determine how PI3K catalytic isoforms become dysregulated in glioblastoma. Background: Recurrence in glioblastoma (GBM) i...
Abstract 54: PI3K-directed metabolic reprogramming in thyroid cancer
Abstract 54: PI3K-directed metabolic reprogramming in thyroid cancer
Abstract Tumor cells reprogram their metabolic pathway to meet their energetic needs during tumor progression. Highly proliferating or transformed cells are able to ...
Abstract 1785: Neprilysin: A potential regulator of PI3K/AKT signaling in triple negative breast cancer cells
Abstract 1785: Neprilysin: A potential regulator of PI3K/AKT signaling in triple negative breast cancer cells
Abstract Triple-negative breast cancers (TNBC) are among the most aggressive and therapeutically resistant breast cancers and comprise approximately 15-20% of all br...
Abstract 4697: The PI3K/mTOR pathway is a potential therapeutic target in cancers with ARID1A mutations
Abstract 4697: The PI3K/mTOR pathway is a potential therapeutic target in cancers with ARID1A mutations
Abstract The chromatin remodeling SWI/SNF complex is mutated in 20% of all cancers and ARID1A is the most frequently mutated subunit. However, the tumor suppressive ...
Data from PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas
Data from PAK1 Mediates Resistance to PI3K Inhibition in Lymphomas
<div>Abstract<p><b>Purpose:</b> The phosphoinositide 3-kinase (PI3K) pathway is known to play an active role in many malignancies. The role of PI3K inhibiti...

Back to Top